Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System

Ramsey A Lyimo, Jossy van den Boogaard, Elizabeth Msoka, Harm J Hospers, Andre van der Ven, Declare Mushi, Marijn de Bruin

Research output: Contribution to journalArticle

20 Citations (Scopus)
4 Downloads (Pure)

Abstract

Background
An often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers date and time of pill-bottle openings. Despite its strengths, MEMS-data can be compromised by inaccurate use and acceptability problems due to its design. These barriers remain, however, to be investigated in resource-limited settings. We evaluated the feasibility and acceptability of using MEMS-caps to monitor adherence among HIV-infected patients attending a rural clinic in Tanzania's Kilimanjaro Region.

Methods
Eligible patients were approached and asked to use the MEMS-caps for three consecutive months. Thereafter, qualitative, in-depth interviews about the use of MEMS were conducted with the patients. MEMS-data were used to corroborate the interview results.

Results
Twenty-three of the 24 patients approached agreed to participate. Apart from MEMS-use on travel occasions, patients reported no barriers regarding MEMS-use. Unexpectedly, the MEMS-bottle design reduced the patients' fear for HIV-status disclosure. Patients indicated that having their behavior monitored motivated them to adhere better. MEMS-data showed that most patients had high levels of adherence and there were no bottle-openings that could not be accounted for by medication intake. Non-adherence in the days prior to clinic visits was common and due to the clinic dispensing too few pills.

Conclusion
MEMS-bottle use was readily accepted by patients. Although the MEMS-bottle was used accurately by most patients, patients need to be more explicitly instructed to continue MEMS-use when travelling. Even HIV-clinics with sufficient staff and free medication may impose structural adherence barriers by supplying an insufficient amount of pills.
Original languageEnglish
Article number92
Number of pages7
JournalBMC Public Health
Volume11
DOIs
Publication statusPublished - 9 Feb 2011

Fingerprint

Tanzania
Information Systems
Therapeutics
HIV
Interviews
Disclosure
Ambulatory Care
Fear

Keywords

  • adult
  • anti-retroviral agents
  • drug packaging
  • electronics
  • feasibility studies
  • female
  • HIV infections
  • HIV-1
  • humans
  • interviews as topic
  • male
  • middle aged
  • patient compliance
  • Tanzania

Cite this

Measuring adherence to antiretroviral therapy in northern Tanzania : feasibility and acceptability of the Medication Event Monitoring System. / Lyimo, Ramsey A; van den Boogaard, Jossy; Msoka, Elizabeth; Hospers, Harm J; van der Ven, Andre; Mushi, Declare; de Bruin, Marijn.

In: BMC Public Health, Vol. 11, 92, 09.02.2011.

Research output: Contribution to journalArticle

Lyimo, Ramsey A ; van den Boogaard, Jossy ; Msoka, Elizabeth ; Hospers, Harm J ; van der Ven, Andre ; Mushi, Declare ; de Bruin, Marijn. / Measuring adherence to antiretroviral therapy in northern Tanzania : feasibility and acceptability of the Medication Event Monitoring System. In: BMC Public Health. 2011 ; Vol. 11.
@article{1a15f3d64b934174b8fed9fd56da91d4,
title = "Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System",
abstract = "BackgroundAn often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers date and time of pill-bottle openings. Despite its strengths, MEMS-data can be compromised by inaccurate use and acceptability problems due to its design. These barriers remain, however, to be investigated in resource-limited settings. We evaluated the feasibility and acceptability of using MEMS-caps to monitor adherence among HIV-infected patients attending a rural clinic in Tanzania's Kilimanjaro Region.MethodsEligible patients were approached and asked to use the MEMS-caps for three consecutive months. Thereafter, qualitative, in-depth interviews about the use of MEMS were conducted with the patients. MEMS-data were used to corroborate the interview results.ResultsTwenty-three of the 24 patients approached agreed to participate. Apart from MEMS-use on travel occasions, patients reported no barriers regarding MEMS-use. Unexpectedly, the MEMS-bottle design reduced the patients' fear for HIV-status disclosure. Patients indicated that having their behavior monitored motivated them to adhere better. MEMS-data showed that most patients had high levels of adherence and there were no bottle-openings that could not be accounted for by medication intake. Non-adherence in the days prior to clinic visits was common and due to the clinic dispensing too few pills.ConclusionMEMS-bottle use was readily accepted by patients. Although the MEMS-bottle was used accurately by most patients, patients need to be more explicitly instructed to continue MEMS-use when travelling. Even HIV-clinics with sufficient staff and free medication may impose structural adherence barriers by supplying an insufficient amount of pills.",
keywords = "adult, anti-retroviral agents, drug packaging, electronics, feasibility studies, female, HIV infections, HIV-1, humans, interviews as topic, male, middle aged, patient compliance, Tanzania",
author = "Lyimo, {Ramsey A} and {van den Boogaard}, Jossy and Elizabeth Msoka and Hospers, {Harm J} and {van der Ven}, Andre and Declare Mushi and {de Bruin}, Marijn",
year = "2011",
month = "2",
day = "9",
doi = "10.1186/1471-2458-11-92",
language = "English",
volume = "11",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Measuring adherence to antiretroviral therapy in northern Tanzania

T2 - feasibility and acceptability of the Medication Event Monitoring System

AU - Lyimo, Ramsey A

AU - van den Boogaard, Jossy

AU - Msoka, Elizabeth

AU - Hospers, Harm J

AU - van der Ven, Andre

AU - Mushi, Declare

AU - de Bruin, Marijn

PY - 2011/2/9

Y1 - 2011/2/9

N2 - BackgroundAn often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers date and time of pill-bottle openings. Despite its strengths, MEMS-data can be compromised by inaccurate use and acceptability problems due to its design. These barriers remain, however, to be investigated in resource-limited settings. We evaluated the feasibility and acceptability of using MEMS-caps to monitor adherence among HIV-infected patients attending a rural clinic in Tanzania's Kilimanjaro Region.MethodsEligible patients were approached and asked to use the MEMS-caps for three consecutive months. Thereafter, qualitative, in-depth interviews about the use of MEMS were conducted with the patients. MEMS-data were used to corroborate the interview results.ResultsTwenty-three of the 24 patients approached agreed to participate. Apart from MEMS-use on travel occasions, patients reported no barriers regarding MEMS-use. Unexpectedly, the MEMS-bottle design reduced the patients' fear for HIV-status disclosure. Patients indicated that having their behavior monitored motivated them to adhere better. MEMS-data showed that most patients had high levels of adherence and there were no bottle-openings that could not be accounted for by medication intake. Non-adherence in the days prior to clinic visits was common and due to the clinic dispensing too few pills.ConclusionMEMS-bottle use was readily accepted by patients. Although the MEMS-bottle was used accurately by most patients, patients need to be more explicitly instructed to continue MEMS-use when travelling. Even HIV-clinics with sufficient staff and free medication may impose structural adherence barriers by supplying an insufficient amount of pills.

AB - BackgroundAn often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers date and time of pill-bottle openings. Despite its strengths, MEMS-data can be compromised by inaccurate use and acceptability problems due to its design. These barriers remain, however, to be investigated in resource-limited settings. We evaluated the feasibility and acceptability of using MEMS-caps to monitor adherence among HIV-infected patients attending a rural clinic in Tanzania's Kilimanjaro Region.MethodsEligible patients were approached and asked to use the MEMS-caps for three consecutive months. Thereafter, qualitative, in-depth interviews about the use of MEMS were conducted with the patients. MEMS-data were used to corroborate the interview results.ResultsTwenty-three of the 24 patients approached agreed to participate. Apart from MEMS-use on travel occasions, patients reported no barriers regarding MEMS-use. Unexpectedly, the MEMS-bottle design reduced the patients' fear for HIV-status disclosure. Patients indicated that having their behavior monitored motivated them to adhere better. MEMS-data showed that most patients had high levels of adherence and there were no bottle-openings that could not be accounted for by medication intake. Non-adherence in the days prior to clinic visits was common and due to the clinic dispensing too few pills.ConclusionMEMS-bottle use was readily accepted by patients. Although the MEMS-bottle was used accurately by most patients, patients need to be more explicitly instructed to continue MEMS-use when travelling. Even HIV-clinics with sufficient staff and free medication may impose structural adherence barriers by supplying an insufficient amount of pills.

KW - adult

KW - anti-retroviral agents

KW - drug packaging

KW - electronics

KW - feasibility studies

KW - female

KW - HIV infections

KW - HIV-1

KW - humans

KW - interviews as topic

KW - male

KW - middle aged

KW - patient compliance

KW - Tanzania

U2 - 10.1186/1471-2458-11-92

DO - 10.1186/1471-2458-11-92

M3 - Article

VL - 11

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

M1 - 92

ER -